Loss of DICER is associated with increased tumorigenicity and with poor patient prognosis in several cancers [25–27], DICER downregulation has been reported in colorectal cancer with low DICER expression associated with advanced, high grade tumors and poor patient outcome [48]. This evidence concerns the gene DICER1 and colorectal cancer.